New information on finding a coronavirus treatment

Dr. Andre Kahlil from The University of Nebraska Medical Center breaks down the process for developing a drug to treat COVID-19.
4:41 | 02/28/20

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for New information on finding a coronavirus treatment
And the big question many are now wondering is how close are we to finding a solution to the outbreak. And how long can this go on for joining us now is a person leading the charge to try to find a solution here in the US. Doctor on critically ill from the University of Nebraska Medical Center doctor Cleo first off I know you're busy so thank you for taking the time to speak to us. Thanks for having seen how far along are we in developing a drug to treat covad nineteen. So we you know we we decide sticky a little bit of a different approach is time we designed. The clinical trial to be available to different drugs so we of the trial that we designed with the National Institutes of Health NIH. He's a trial that will be what he called randomized adaptive trials so the trial will VA would to test several different drugs sequentially. The first drug they're gonna tests is and as a veers so this is an indication that has already a track record off a viral replication in aviation so we we looked into in vitro and animal site is. And found that his medication has to do is our ability to win here derive the viral replication so the idea here is to test. This medication as the first one in the trial also half of the patients. We will receive government has appeared and got to have his and received the placebo and the idea here is to run this trial pass fast as possible. To find it's his medication works if his medication works we announced we gonna work in what's called an adaptive process. The medication will be transferred to the control arm and remembering a new medication and processor communication and then can pass a certain medications so forth so the idea is to. Have this clinical prior running. As long as possible we have now a plan to run for at least three years. And we gonna test symbol for drugs so hopefully gonna find that they wouldn't get one or more therapists. Dead skin I mean you can just improved the clinical symptoms and the survival of this patients with severe. Called in nineteen very important to to mention that the trial really is focused on V patients who is a moderate and severe disease. Had you know as you know 80% eighty to 90% of the patients today. We'll have just a mild disease they will basically get cured just on their wrong they will not need in his specific medications. The focus of this clinical trial is. To try to help the people that I need the most people that the gonna have the severe diseases diseases affect the lungs and can cause pneumonia. So what can you tell us about the participants in this trial as well as the corona virus cases that you are already treating. So the you know I cannot tell little any specifics about the frustration on their trial but I can tell that the patient. It keeps improving and and action was discharging from. From the by Clinton units back to quarantine yes that is so mean and that the patient really had a significant improvement being the clinical trial. We've this as I mentioned before is a randomized trial of the mobile I'm so we don't know which medications that they should receive the policy of the hogs for injecting drug but the patient improve demonstration was discharged from the hospital. We have water fourteen patients stats are in the quarantine. That means they need to botch required to be in I mean it's an awesome because they don't have any severe disease though have mild disease. So at this point patients are doing well they're improving. But we are observing very carefully because what we've bonus weave his affectionate sometimes. Hi takes about a week that we can have four the disease progress and you know gain to the lines and president one and so we have to keep very. Close attention teacher and if this patients. Let's get to know I know the York facility also dealt with the Ebola Virus outbreak in 2014. So far how does your experience with these two scenarios compare. I think to compare. Differently but we you know we learned so much in 2014. Through both of the clinical aspects and restored suspects for instance. The trial that we have on the clinical try to to have an hour is basically is and is being built. On what to Lauren we the trials that reviewed dependable outbreaks so we are much better. I'm doing this type of recession on days trying to bring this sheriff is because we. We're learning. On the time debt to we went through this 1004 outbreaks so definitely it's a he learning car of but the lessons we learned danced on the fourteenth are definitely being very useful for what's happening today. All right doctor on nickel -- from the University of Nebraska Medical Center. We appreciate your time doctor as well as the work that you're doing thank you.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"4:41","description":"Dr. Andre Kahlil from The University of Nebraska Medical Center breaks down the process for developing a drug to treat COVID-19. ","mediaType":"default","section":"ABCNews/US","id":"69268034","title":"New information on finding a coronavirus treatment ","url":"/US/video/information-finding-coronavirus-treatment-69268034"}